Paper1663589
Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Cai.
Schudt C and 4 others. Naunyn Schmiedebergs Arch Pharmacol, 1991. Cited by 117 papers, by iCite.
Cite this record
ConductScience Library. Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Cai. Papers, record 1663589. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1663589
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Cai.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcium | Major topic |
| Cyclic AMP | Major topic |
| Neutrophils | Major topic |
| Phosphodiesterase Inhibitors | Major topic |
| Arachidonate 5-Lipoxygenase | |
| Humans | |
| Isoenzymes | |
| Leukotrienes |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3003053 | Inhibitory effect of prostaglandin E2, forskolin, and dibutyryl cAMP on arachidonic acid release and inositol phospholipid metabolism in guinea pig neutrophils. | J Biol Chem | 1986 | https://conductscience.org/library/papers/3003053 | PubMed |
| 2 | 3037956 | Cyclic AMP-dependent regulation of lipid mediators in white cells. A unifying concept for explaining the efficacy of theophylline in asthma. | Am Rev Respir Dis | 1987 | https://conductscience.org/library/papers/3037956 | PubMed |
| 3 | 2158847 | The effects of siguazodan, a selective phosphodiesterase inhibitor, on human platelet function. | Br J Pharmacol | 1990 | https://conductscience.org/library/papers/2158847 | PubMed |
| 4 | 6315792 | Evidence that the functional responses of human neutrophils occur independently of transient elevations in cyclic AMP levels. | J Cyclic Nucleotide Protein Phosphor Res | 1983 | https://conductscience.org/library/papers/6315792 | PubMed |
| 5 | 2581959 | Chemoattractant-elicited alterations of cAMP levels in human polymorphonuclear leukocytes require a Ca2+-dependent mechanism which is independent of transmembrane activation of adenylate cyclase. | J Biol Chem | 1985 | https://conductscience.org/library/papers/2581959 | PubMed |
| 6 | 3011441 | Inhibition of human neutrophil degranulation by forskolin in the presence of phosphodiesterase inhibitors. | Eur J Pharmacol | 1986 | https://conductscience.org/library/papers/3011441 | PubMed |
| 7 | 3006691 | Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Isolation, characterization, and effects of various reference phosphodiesterase inhibitors and cardiotonic agents. | Biochem Pharmacol | 1986 | https://conductscience.org/library/papers/3006691 | PubMed |
| 8 | 2447991 | Effects of phosphodiesterase inhibitors on normal and chemically-skinned isolated airway smooth muscle. | Br J Pharmacol | 1987 | https://conductscience.org/library/papers/2447991 | PubMed |
| 9 | 2824200 | Regulation of 5-lipoxygenase activity by the glutathione status in human polymorphonuclear leukocytes. | Eur J Biochem | 1987 | https://conductscience.org/library/papers/2824200 | PubMed |
| 10 | 2542050 | The role of cyclic AMP in the inhibition of leukotriene biosynthesis by neuropeptides. | Eur J Pharmacol | 1989 | https://conductscience.org/library/papers/2542050 | PubMed |
| 11 | 1648920 | Zardaverine as a selective inhibitor of phosphodiesterase isozymes. | Biochem Pharmacol | 1991 | https://conductscience.org/library/papers/1648920 | PubMed |
| 12 | 3007354 | Calmodulin-dependency of human neutrophil phosphodiesterase. | Inflammation | 1986 | https://conductscience.org/library/papers/3007354 | PubMed |
| 13 | 2153973 | Immunocytology on microwave-fixed cells reveals rapid and agonist-specific changes in subcellular accumulation patterns for cAMP or cGMP. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/2153973 | PubMed |
| 14 | 6245105 | Increased levels of cyclic adenosine-3',5'-monophosphate in human polymorphonuclear leukocytes after surface stimulation. | J Clin Invest | 1980 | https://conductscience.org/library/papers/6245105 | PubMed |
| 15 | 1977788 | Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst. | J Allergy Clin Immunol | 1990 | https://conductscience.org/library/papers/1977788 | PubMed |
| 16 | 2683636 | Is phosphodiesterase inhibition a relevant bronchospasmolytic principle? | Agents Actions Suppl | 1989 | https://conductscience.org/library/papers/2683636 | PubMed |
| 17 | 3036066 | The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors. | Biochem J | 1987 | https://conductscience.org/library/papers/3036066 | PubMed |
| 18 | 2991233 | Proteolytic activation of calmodulin-dependent cyclic nucleotide phosphodiesterase. | J Biol Chem | 1985 | https://conductscience.org/library/papers/2991233 | PubMed |
| 19 | 2159198 | Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. | Trends Pharmacol Sci | 1990 | https://conductscience.org/library/papers/2159198 | PubMed |
| 20 | 1665311 | Zardaverine: a cyclic AMP specific PDE III/IV inhibitor. | Agents Actions Suppl | 1991 | https://conductscience.org/library/papers/1665311 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35806233 | Inhibition of Recruitment and Activation of Neutrophils by Pyridazinone-Scaffold-Based Compounds. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35806233 | PubMed |
| 30112056 | Study on the clinical efficacy of specific phosphodiesterase inhibitor in patients with pulmonary hypertension due to left heart disease. | Exp Ther Med | 2018 | https://conductscience.org/library/papers/30112056 | PubMed |
| 20050849 | Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis. | Br J Pharmacol | 2010 | https://conductscience.org/library/papers/20050849 | PubMed |
| 19572173 | Inhibition of HA synthase 3 mRNA expression, with a phosphodiesterase 3 inhibitor, blocks lung injury in a septic ventilated rat model. | Lung | 2009 | https://conductscience.org/library/papers/19572173 | PubMed |
| 18972099 | Inhaled milrinone attenuates experimental acute lung injury. | Intensive Care Med | 2009 | https://conductscience.org/library/papers/18972099 | PubMed |
| 18941502 | Effects of phosphodiesterase 4 inhibition on alveolarization and hyperoxia toxicity in newborn rats. | PLoS One | 2008 | https://conductscience.org/library/papers/18941502 | PubMed |
| 17465639 | Steady-state pharmacokinetics of roflumilast and roflumilast N-oxide in patients with mild and moderate liver cirrhosis. | Clin Pharmacokinet | 2007 | https://conductscience.org/library/papers/17465639 | PubMed |
| 16501579 | Inhibition of superoxide anion and elastase release in human neutrophils by 3'-isopropoxychalcone via a cAMP-dependent pathway. | Br J Pharmacol | 2006 | https://conductscience.org/library/papers/16501579 | PubMed |
| 14744809 | Histamine-induced inhibition of leukotriene biosynthesis in human neutrophils: involvement of the H2 receptor and cAMP. | Br J Pharmacol | 2004 | https://conductscience.org/library/papers/14744809 | PubMed |
| 14559857 | Effect of two phenanthrene alkaloids on angiotensin II-induced leukocyte-endothelial cell interactions in vivo. | Br J Pharmacol | 2003 | https://conductscience.org/library/papers/14559857 | PubMed |
| 11139438 | The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C(4)-induced contractions in passively sensitized human airways. | Br J Pharmacol | 2000 | https://conductscience.org/library/papers/11139438 | PubMed |
| 10730545 | Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here? | Drugs | 2000 | https://conductscience.org/library/papers/10730545 | PubMed |
| 10455321 | Bronchodilator and anti-inflammatory activities of glaucine: In vitro studies in human airway smooth muscle and polymorphonuclear leukocytes. | Br J Pharmacol | 1999 | https://conductscience.org/library/papers/10455321 | PubMed |
| 10369473 | Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity. | Br J Pharmacol | 1999 | https://conductscience.org/library/papers/10369473 | PubMed |
| 10193778 | The effects of phosphodiesterase type 4 inhibitors on tumour necrosis factor-alpha and leukotriene B4 in a novel human whole blood assay. | Br J Pharmacol | 1999 | https://conductscience.org/library/papers/10193778 | PubMed |
| 9824770 | Anti-oxidative effects of theophylline on human neutrophils involve cyclic nucleotides and protein kinase A. | Inflammation | 1998 | https://conductscience.org/library/papers/9824770 | PubMed |
| 9624300 | New therapies for chronic obstructive pulmonary disease. | Thorax | 1998 | https://conductscience.org/library/papers/9624300 | PubMed |
| 8872362 | Effects of SCA40 on human isolated bronchus and human polymorphonuclear leukocytes: comparison with rolipram, SKF94120 and levcromakalim. | Br J Pharmacol | 1996 | https://conductscience.org/library/papers/8872362 | PubMed |
| 8680723 | Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils. | Br J Pharmacol | 1995 | https://conductscience.org/library/papers/8680723 | PubMed |
| 8386187 | Role of phosphodiesterases in the regulation of endothelial permeability in vitro. | J Clin Invest | 1993 | https://conductscience.org/library/papers/8386187 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ALOX5 | 240 | PubTator's text mining | https://conductscience.org/library/genes/240 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1663589
GET https://conductscience.org/api/papers/v1/1663589/references?page=2